CSL Limited
Save
–
Market cap
35.04x
Current P/E
30.86x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Similar securities
Based on sector and market capitalization
Report issue